Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 1, 2009, Pages 52-56

  Gracia, Matilde ^a   Díaz, Carolina ^a   Coronel, Pilar ^b   Gimeno, Mercedes ^b   García Rodas, Rocío ^a   Rodríguez Cerrato, Violeta ^a   del Prado, Gema ^a   Huelves, Lorena ^a   Ruiz, Vicente ^a   Naves, Plínio F L ^a   Ponte, Maria Carmen ^a   Granizo, Juan José ^c   Soriano, Francisco ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Tedec Meiji Farma SA   (Spain)

^c Granadata   (Spain)

Author keywords

Antimicrobial susceptibility; Cefditoren; Europe; Macrolides; Streptococcus pyogenes; Surveillance

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFDITOREN; CEFOTAXIME; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN G; ANTIINFECTIVE AGENT; BETA LACTAM; OFLOXACIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; BALTIC STATES; CHILD; CONTROLLED STUDY; CZECH REPUBLIC; DRUG SURVEILLANCE PROGRAM; EASTERN EUROPE; ESTONIA; FEMALE; HUMAN; HUNGARY; IN VITRO STUDY; ISOLATION PROCEDURE; LATVIA; LITHUANIA; LOWER RESPIRATORY TRACT INFECTION; MALE; NONHUMAN; PHENOTYPE; POLAND; PREVALENCE; PRIORITY JOURNAL; ROMANIA; SKIN INFECTION; SLOVAKIA; SOFT TISSUE INFECTION; STREPTOCOCCUS PYOGENES; UPPER RESPIRATORY TRACT INFECTION; DRUG EFFECT; EUROPE; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STREPTOCOCCUS INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHILD; DRUG RESISTANCE, BACTERIAL; EUROPE; FEMALE; HUMANS; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 65649143824     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.12.018     Document Type: Article

References (22)

1. Bandak S.I., Turnak M.R., Allen B.S., Bolzon L.D., and Preston D.A. Oral antimicrobial susceptibilities of Streptococcus pyogenes recently isolated in five countries. Int. J. Clin. Pract. 54 (2000) 585-588
2. Beekmann S.E., Heilmann K.P., Richter S.S., García-de-Lomas J., Doern G.V., and The GRASP Study Group. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program. Int. J. Antimicrob. Agents 25 (2005) 148-156
3. Biedenbach D.J., Toleman M.A., Walsh T.R., and Jones R.N. Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY Antimicrobial Surveillance Program (1997-2004). Diagn. Microbiol. Infect. Dis. 55 (2006) 119-127
4. Bozdogan B., Appelbaum P.C., Kelly L.M., Hoellman D.B., Tambic-Andrasevic A., Drukalska L., Hryniewicz W., Hupkova H., Jacobs M.R., Kolman J., Konkoly-Thege M., Miciuleviciene J., Pana M., Setchanova L., Trupl J., and Urbaskova P. Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and Eastern Europe. Clin. Microbiol. Infect. 9 (2003) 741-745
5. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 16th Informational Supplement (M100-S16) (2006), CLSI, Wayne, PA
6. Gattringer R., Sauermann R., Lagler H., Stich K., Buxbaum A., Graninger W., and Georgopoulos A. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary. Int. J. Antimicrob. Agents 24 (2004) 290-293
7. Granizo J.J., Aguilar L., Casal J., Baquero F., and Dal-Ré R. Erythromycin resistance in Streptococcus pyogenes in relationship with macrolide consumption in Spain (1986-1997). J. Antimicrob. Chemother. 46 (2000) 959-964
8. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34 (2002) 482-492
9. Pérez-Trallero E., Fernández-Mazarrasa C., García-Rey C., Bouza E., Aguilar L., García-de-Lomas J., Baquero F., and Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob. Agents Chemother. 45 (2001) 3334-3340
10. Richter S.S., Heilmann K.P., Dohrn C.L., Beekmann S.E., Riahi F., García-de-Lomas J., Ferech M., Goossens H., and Doern G.V. Increasing telithromycin resistance among Streptococcus pyogenes in Europe. J. Antimicrob. Chemother. 61 (2008) 603-611
11. Sawai J., Hasegawa T., Kamimura T., Okamoto A., Ohmori D., Nosaka N., Yamada K., Torii K., and Ohta M. Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob. Agents Chemother. 51 (2007) 461-467
12. Seppälä H., Nissinen Q.Y., and Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32 (1993) 885-891
13. Seppälä H., Skurnik M., Soini H., Roberts M.C., and Huovinen P. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42 (1998) 257-262
14. Skoczynska A., Kadtubowski M., Wasko I., Fiett J., and Hryniewicz W. Resistance patterns of selected respiratory tract pathogens in Poland. Clin. Microbiol. Infect. 13 (2007) 377-383
15. Soriano F., Granizo J.J., Fernández-Roblas R., Esteban J., Gadea I., Gracia M., Coronel P., Gimeno M., and Ródenas E. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from adult patients with respiratory tract and skin and soft tissue infections in four southern European countries. J. Chemother. 15 (2003) 293-295
16. Spectracef [package insert] (2001), TAP Pharmaceuticals, Lake Forest (Ill)
17. Sutcliffe J., Tait-Kamradt A., and Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40 (1996) 1817-1824
18. Szczypa K., Sadowy E., Izdebski R., and Hryniewicz W. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J. Antimicrob. Chemother. 54 (2004) 828-831
19. Urbásková P., Jakubu V., and Pracovní skupina pro monitorování antibiotické rezistence. Resistance to macrolides in the species Streptococcus pyogenes in the Czech Republic in 1996-2003 (Article in Czech). Epidemiol. Mikrobiol. Imunol. 53 (2004) 196-202
20. Wellington K., and Curran M.P. Cefditoren pivoxil. A review of its use in the treatment of bacterial infections. Drugs 64 (2004) 2597-2618
21. Yan S.S., Fox M.L., Holland S.M., Stock F., Gill V.J., and Fedorko D.P. Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance. Antimicrob. Agents Chemother. 44 (2000) 3196-3198
22. Yan S.S., Schreckenberger P.C., Zheng X., Nelson N.A., Harrington S.M., Tjhio J., and Fedorko D.P. An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes. Diagn. Microbiol. Infect. Dis. 62 (2008) 205-209